.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cardiorenal syndrome (CRS) represents the complex, bidirectional interplay between cardiac and renal systems. Understanding how kidney dysfunction triggers heart failure requires robust cardiorenal syndrome models. This interaction is particularly evident in CRS types 3 and 4, which describe how kidney failure impacts the heart. Specifically, type 3 refers to acute kidney injury (AKI) leading to acute heart failure, while type 4 involves chronic kidney disease (CKD) causing chronic heart failure. Consequently, these conditions carry significant morbidity and mortality risks for patients worldwide.
The transition from renal impairment to cardiovascular events involves several sophisticated pathways. Systemic inflammation, oxidative stress, and endothelial damage act as primary drivers. Additionally, neurohormonal activation, including the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS), further exacerbates cardiac strain. Moreover, uremic toxins and electrolyte imbalances specifically impair myocardial contractility. Because these mechanisms are multifaceted, researchers rely on preclinical investigations to isolate specific pathways for potential therapy.
Preclinical research uses various cardiorenal syndrome models to simulate human disease states. For instance, the 5/6 nephrectomy and adenine-induced injury models successfully mimic chronic renal failure seen in CRS type 4. In contrast, renal ischemia-reperfusion and cisplatin-induced injury provide insights into the acute phase of CRS type 3. Furthermore, unilateral ureteral obstruction (UUO) remains a valuable tool for studying renal fibrosis and its subsequent cardiac impact. However, these rodent models have limitations, as they often fail to capture the full spectrum of human comorbidities like aging and diabetes. Therefore, refining these models is essential for developing targeted therapies.
Advancing our understanding of CRS requires a shift toward more clinically relevant preclinical designs. Researchers must prioritize models that incorporate common human risk factors to enhance translatability. Furthermore, identifying novel biomarkers through these models may improve early diagnosis. Ultimately, the goal remains to bridge the gap between fundamental science and clinical application to improve patient outcomes in cardiorenal care.
Type 3 cardiorenal syndrome occurs when an episode of acute kidney injury (AKI) directly leads to acute cardiac dysfunction, such as heart failure, arrhythmia, or ischemia.
The 5/6 nephrectomy and adenine-induced kidney injury models are frequently used to study chronic kidney disease (CRS type 4) and its long-term effects on cardiac hypertrophy and fibrosis.
Preclinical models allow scientists to investigate specific molecular mechanisms like oxidative stress and inflammation, which are difficult to isolate in human clinical trials.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Figueroa SM et al. Experimental rodent models of cardiorenal syndrome types 3 and 4: Insights and clinical relevance (Review). Int J Mol Med. 2026 Aug undefined. doi: undefined. PMID: 42246189.
Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019;139(16):e840-e891.
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-1539.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of experimental rodent models for Cardiorenal Syndrome types 3 and 4, exploring the pathophysiology and limitations of current research models....
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
